Senores Pharmaceuticals Limited held its Extra-Ordinary General Meeting (EGM) on January 31, 2026, commencing at 12:30 P.M. IST, conducted through Video Conference/Other Audio Visual Means. The primary agenda of the EGM was to approve the issuance of 11,70,000 Convertible Equity Warrants via a preferential issue to persons belonging to the Promoter and Promoter Group categories. The voting results, consolidated from remote e-voting and e-voting during the EGM, indicate overwhelming support for the resolution. The total votes polled were 18,111,053 out of 46,053,588 shares, representing 39.326% of outstanding shares. Of these, 17,469,008 votes were cast in favour (96.455% of votes polled), and 642,045 votes were against (3.545% of votes polled), leading to the resolution being passed. Specifically, the Promoter and Promoter Group cast all their polled votes (10,279,783) in favour of the resolution. Public Institutions voted 74.7873% in favour (1,904,471 votes) and 25.2127% against (642,044 votes). Public Non-Institutions also showed strong support, with 100% of their polled votes (5,284,754) in favour and only 1 against. The company has submitted the Consolidated Report of the Scrutinizer and the Voting Results as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, to the BSE Limited and the National Stock Exchange of India Limited.
